Scholars Central

Review articlePublished 27 Aug 2019

Pharmacologic Treatment of Attention Deficit Disorder in Children and Adolescents: Executive Function Agents, Stimulants, and Sympathomimetic Amines

Authors: Ryan Mast, Bethany Harper, Kaitlyn Pollock, Julie P Gentile

Journal of Clinical Medicine and Therapeutics

Volume 4 · Issue 1 · Pages 1

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

In the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children and adolescents, the prescriber may consider both stimulants and non-stimulant medications; in addition, there are some over the counter substances and adjunct medications that may be helpful in mitigation or resolution of symptoms. Behavioral, environmental and psycho-social approaches should be instituted in association with pharmacology and extra caution and conservatism should be used in all children and adolescent patients. When making clinical decisions, it is important to consider use of both immediate release and sustained release stimulant preparations, as well as to carefully consider first line agents as well as second line or adjunct agents. It has been long recognized that the prominent central nervous system neurochemicals intimately involved with ADHD symptoms affect dopamine and/or norepinephrine receptor systems.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Medicine and Therapeutics
  • SubjectGeneral & Internal Medicine
  • BylineArticles whose byline prints “Ryan Mast”
  • BylineArticles whose byline prints “Bethany Harper”
  • BylineArticles whose byline prints “Kaitlyn Pollock”
  • BylineArticles whose byline prints “Julie P Gentile”